Achieving delicious wraps is all about balancing the right blend of ingredients. These three wraps are made with carefully ...

After a long run of regulatory stumbles and the recent withdrawal of its lone commercial drug from the U.S. market, Intercept Pharmaceuticals is implementing a restructuring and rounds of job cuts in ...

Hummus, a popular dip made with chickpeas, tahini, oil, and lemon juice, may aid weight loss. People may want to lose weight for various reasons, which can relate to improving their health, and their ...

With just a food processor, canned chickpeas, and ice-cold water, you can make the creamiest hummus and tahini sauce at home. Once you learn the trick, store-bought won’t compare. Steve Cook is an ...

While the path for any drug to go from lab research to commercialization takes years, Intercept Pharmaceuticals now stands as another example that a product’s market exit can also be long and winding.

Please provide your email address to receive an email when new articles are posted on . Intercept has voluntarily withdrawn its lone product, Ocaliva, from U.S. market for primary biliary cholangitis.

Sept 11 (Reuters) - Intercept Pharmaceuticals said on Thursday it is withdrawing its liver disease drug from the U.S. market following a request from the Food and Drug Administration. This comes as ...

After years of regulatory struggles for Intercept Pharmaceuticals and its liver disease drug Ocaliva (obeticholic acid), the FDA has called time on the drug's run in the U.S. market. The agency placed ...